MétaCan
Menu
← Back to cohort
Record W3148783972 · doi:10.31128/ajgp-02-20-5222

Management of patients with type 2 diabetes and cardiovascular disease in primary care

2021· article· en· W3148783972 on OpenAlexaff
Andrew Marson, Natalie Raffoul, Rawa Osman, Gary Deed

Bibliographic record

VenueAustralian Journal of General Practice · 2021
Typearticle
Languageen
FieldMedicine
TopicDiabetes Treatment and Management
Canadian institutionsMicropharma (Canada)
Fundersnot available
KeywordsMedicineDiabetes mellitusType 2 diabetesDiseaseLife expectancyBlood pressureMetforminDiabetes managementIntensive care medicineInternal medicineEmergency medicinePopulationEnvironmental healthEndocrinology

Abstract

fetched live from OpenAlex

Background and objectiveApproximately 65% of cardiovascular disease (CVD)-related deaths in Australia occur in people with diabetes or pre-diabetes.The aim of this study was to investigate general practice management of risk factors among patients with both conditions. MethodsThis was a cross-sectional study of 33,559 adult patients with both type 2 diabetes and CVD at 1 November 2018, using the general practice data program MedicineInsight. ResultsOne-third of patients did not have a record in their current medications list for all three recommended medicines to reduce cardiovascular risk.Potentially suboptimal monitoring and achievement of targets for diabetes and cardiovascular risk factors was also identified.Most patients using metformin-based combination therapy were prescribed blood glucose-lowering medicines that do not have evidence of cardiovascular benefit. DiscussionThese data suggest opportunities to support general practices to optimise patient management.Datasets such as MedicineInsight can help practices identify patients who may benefit from recall.APPROXIMATELY 65% of all cardiovascular disease (CVD)-related deaths in Australia occur in people with diabetes or pre-diabetes.1 The mortality rate in people with type 2 diabetes (T2D) almost doubles with the coexistence of CVD, resulting in an estimated 12-year reduction in life expectancy.2 Typically, people with T2D experience atherosclerotic CVD earlier and with greater severity than people without T2D.3 Despite their significantly elevated risk, suboptimal prescribing of blood pressure (BP)-lowering, 4,5 lipid-modifying 4-6 and antiplatelet therapy 5 for patients with diabetes and CVD has been reported in Australian primary care.Australian data also show that many patients with diabetes and/or CVD do not meet guideline recommendations for prescribing, 4-10 monitoring and treatment targets for managing cardiovascular risk.5,7 Blood glucose-lowering medicine (GLM) selection is also increasingly complex because of the increase in available medicines, and the focus on cardiovascular safety since the US Food and Drug Administration mandated in 2008 that all new studies must demonstrate cardiovascular safety.11 Several trials have shown not only cardiovascular safety, but also additional cardiovascular and renal benefits over placebo.[12][13][14][15][16][17][18][19][20] The aim of this study was to investigate management of T2D and atherosclerotic CVD risk factors in general practice, using MedicineInsight data to explore medicines prescribed, monitoring performed and achievement of treatment targets.The study was part of a quality improvement program that ran from June 2018 to April 2019 and involved presenting practicelevel data to general practitioners (GPs) at small group meetings to identify opportunities for improvement in clinical care. MethodsA cross-sectional study was conducted using MedicineInsight, a large national general practice database developed and managed by NPS MedicineWise, with funding support from the Australian Government Department of Health.21 MedicineInsight extracts longitudinal, de-identified patient health records including demographics, encounters, diagnoses, prescriptions and pathology tests from Best Practice and Medical Director clinical information systems in participating practices.In October 2018, MedicineInsight had recruited 662 practices across Australia, representing approximately 8.2% of all general practices in Australia and more than 2700 GPs.21 MedicineInsight has national coverage across all states and territories.Practices are recruited to MedicineInsight using non-random sampling.In comparison to national data, Management of patients with type 2 diabetes and cardiovascular disease in primary care

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.009
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: none
Teacher disagreement score0.028
Threshold uncertainty score0.056

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.009
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.002
Science and technology studies0.0010.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.012
GPT teacher head0.246
Teacher spread0.234 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations9
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueAustralian Journal of General Practice→Same topicDiabetes Treatment and Management→French-language works237,207→